» Articles » PMID: 34136362

Introspective Accuracy for Substance Use Across a Year of Treatment for First Episode Psychosis

Overview
Specialty Psychology
Date 2021 Jun 17
PMID 34136362
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Substance use exacerbates psychosis, mania, depression, and poor functioning in people with first episodes of psychosis (FEP) and is associated with poor treatment outcomes, even when it does not reach the level of a formal disorder. Impaired insight and substance use are common issues that may interfere with treatment outcomes among people experiencing FEP, yet both are treatable. Improvements in these domains are associated with better outcomes. Low insight could increase risk for substance use by impairing the ability to self-appraise and assess consequences. Introspective accuracy (IA) is understudied in this area and is one way of considering self-appraisal. This study is an archival review using data collected from NAVIGATE, a coordinated specialty care program treating people with FEP. IA was operationalized as the difference between clinician and client ratings of substance use. We tested whether IA changed over one year of treatment and whether those changes occurred alongside changes in symptoms and illness self-management. No changes in IA were detected in relation to illness self-management. Changes in IA for substance use occurred midway through treatment-individuals with greater symptom remission had more overconfident IA. Prior research on insight has shown a paradox where greater insight accompanies more symptoms. However, past research has also shown a relationship between IA and functional outcomes, like illness self-management, and that overconfidence in one domain can positively bias clinician ratings in another. Our findings suggest either a positive bias for ratings associated with overconfident IA or an insight paradox type effect.

Citing Articles

Interlinking alcohol intake, mental stress, psychotic experiences and job performance of higher institutions' graduates: A structural equation modelling.

Owan V, Duruamaku-Dim J, Okon A, Akah L, Agurokpon D, Ubi I J Educ Health Promot. 2022; 11:312.

PMID: 36439016 PMC: 9683444. DOI: 10.4103/jehp.jehp_417_22.

References
1.
Sklar M, Sarkin A, Gilmer T, Groessl E . The psychometric properties of the Illness Management and Recovery scale in a large American public mental health system. Psychiatry Res. 2012; 199(3):220-7. DOI: 10.1016/j.psychres.2012.03.013. View

2.
Konsztowicz S, Lepage M . The role of illness engulfment in the association between insight and depressive symptomatology in schizophrenia. J Psychiatr Res. 2019; 111:1-7. DOI: 10.1016/j.jpsychires.2018.11.001. View

3.
Czobor P, Van Dorn R, Citrome L, Kahn R, Fleischhacker W, Volavka J . Treatment adherence in schizophrenia: a patient-level meta-analysis of combined CATIE and EUFEST studies. Eur Neuropsychopharmacol. 2015; 25(8):1158-66. PMC: 4860611. DOI: 10.1016/j.euroneuro.2015.04.003. View

4.
Raftery D, Kelly P, Deane F, Baker A, Ingram I, Goh M . Insight in substance use disorder: A systematic review of the literature. Addict Behav. 2020; 111:106549. DOI: 10.1016/j.addbeh.2020.106549. View

5.
Silberstein J, Pinkham A, Penn D, Harvey P . Self-assessment of social cognitive ability in schizophrenia: Association with social cognitive test performance, informant assessments of social cognitive ability, and everyday outcomes. Schizophr Res. 2018; 199:75-82. PMC: 6151277. DOI: 10.1016/j.schres.2018.04.015. View